arrow_back Trending Legislation
Share share

Glioblastoma Awareness Day: Boosting Research and Support for Patients.

The U.S. Senate designated July 19, 2023, as Glioblastoma Awareness Day to highlight this aggressive brain cancer. The resolution aims to increase public knowledge, honor patients and caregivers, and encourage greater investment in research for new treatments. This action supports research initiatives and potentially accelerates the development of life-saving therapies for those affected.
Key points
Designates July 19 as Glioblastoma Awareness Day to increase public understanding of this deadly brain tumor.
Supports increased funding and collaborative research efforts, including the Glioblastoma Therapeutics Network (GTN).
Honors patients and caregivers and recognizes the critical role of molecular biomarker testing in diagnosis and treatment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Adopted
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A resolution designating July 19, 2023, as "Glioblastoma Awareness Day".
Print number: SRES 257
Sponsor: Sen. Graham, Lindsey [R-SC]
Process start date: 2023-06-15
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Glioblastoma Awareness Day: Boosting Research and Support for Patients.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is SRES 257.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-06-15.

What are the main provisions?

Key points include:

  • Designates July 19 as Glioblastoma Awareness Day to increase public understanding of this deadly brain tumor.
  • Supports increased funding and collaborative research efforts, including the Glioblastoma Therapeutics Network (GTN).
  • Honors patients and caregivers and recognizes the critical role of molecular biomarker testing in diagnosis and treatment.

What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Graham, Lindsey [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2127-2128; text: CR S2127)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of SRES 257

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health